Active Ingredient History
DTaP-IPV-HepB vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated polio vaccine or DTaP-IPV-Hep B. It protects against the infectious diseases diphtheria, tetanus, pertussis, poliomyelitis, and hepatitis B. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Bacterial Infections (Phase 3)
BCG Vaccine (Phase 4)
Chickenpox (Phase 3)
Diphtheria (Phase 4)
Drug Therapy, Combination (Phase 4)
Fever (Phase 4)
Haemophilus Infections (Phase 3)
Haemophilus influenzae type b (Phase 4)
Healthy Volunteers (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 3)
Hepatitis B (Phase 4)
Immunity (Phase 4)
Immunization (Phase 3)
Infant (Phase 4)
Measles (Phase 3)
Meningitis, Meningococcal (Phase 3)
Meningococcal Infections (Phase 3)
Mumps (Phase 3)
Neisseria meningitidis (Phase 3)
Neoplasms (Phase 2)
Pertussis Vaccine (Phase 4)
Pneumococcal Infections (Phase 3)
Pneumococcal Vaccines (Phase 4)
Pneumonia, Staphylococcal (Phase 3)
Poliomyelitis (Phase 4)
Rotavirus Infections (Phase 3)
Rotavirus Vaccines (Phase 3)
Rubella (Phase 3)
Streptococcal Infections (Phase 4)
Tetanus (Phase 4)
Vaccines (Phase 4)
Virus Diseases (Phase 3)
Whooping Cough (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue